FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366776606> ?p ?o ?g. }

• W4366776606 endingPage "494" @default.
• W4366776606 startingPage "488" @default.
• W4366776606 abstract "To assess the therapeutic effect and adverse effect of intravesical instillation of bacillus Calmette-Guerin (BCG) for treatment of non-muscle invasive bladder cancer (NMIBC) and analyze the independent predictors of patient survival.We retrospectively collected the clinical data from 421 patients (mean age 61.79±11.51 years) with NMIBC, who received intravesical instillation of BCG after surgery in Sun Yat-sen University Cancer Center from September, 2015 to September, 2021. Recurrence-free survival (RFS), progression-free survival (PFS), and disease specific survival (DSS) of the patients were analyzed, and the adverse effects were assessed using Common Terminology Criteria for Adverse Events 5.0. Kaplan-Meier analysis, univariate and multivariate COX regression analyses were used to identify the independent predictors of the patients' survival outcomes.The median follow-up of the patients was 17 months, during which 88 (20.9%) patients experienced recurrence (median time to recurrence of 10 months, range 3-58 months); 40 (9.5%) patients showed tumor progression (median time to progression of 18 months, range 3-50 months); and 14 (3.3%) patients died (median survival time of 30 months, range 8-52 months). Adverse events of grade 1, 2, and 3 occurred in 69, 110, and 23 of the patients, respectively. Survival analysis indicated that an age below 67.5 years (P=0.013), first tumor onset (P < 0.001), solitary tumor (P= 0.010), time to recurrence over one year (P=0.042), low levels of neutrophils (P=0.005), monocytes (P=0.005) and neutrophil/lymphocyte ratio (NLR; P=0.014), and cytokeratin 19 fragment 21-1 (CyFra21-1; P=0.002) were all associated with a higher PFS rate. Multivariate COX analysis suggested that the time of tumor recurrence (P=0.007, HR=2.669, 95% CI: 1.316-5.414), monocyte counts (P=0.015, HR=0.376, 95% CI: 0.171-0.829), and serum CyFra21-1 level (P=0.002, HR=0.312, 95% CI: 0.151-0.647) were independent predictors of RFS; primary tumor or tumor relapse (P=0.003, HR=0.301, 95% CI: 0.138-0.660), neutrophil counts (P=0.028, HR=0.302, 95% CI: 0.103-0.882), and CyFra21-1 level (P=0.029, HR=0.358, 95% CI: 0.142-0.903) were independent predictors of PFS following BCG instillation.Intravesical instillation of BCG is effective for treatment of intermediate or high-risk NMIBC, and the adverse effects are tolerable in most cases. The time of tumor recurrence, monocyte counts, and serum CyFra21-1 level are independent predictors of RFS, and primary tumor or tumor relapse, neutrophil counts, and CyFra21-1 level are independent predictors of PFS." @default.
• W4366776606 created "2023-04-25" @default.
• W4366776606 creator A5015576939 @default.
• W4366776606 creator A5024922053 @default.
• W4366776606 creator A5029454312 @default.
• W4366776606 creator A5046767109 @default.
• W4366776606 creator A5058775061 @default.
• W4366776606 creator A5068668053 @default.
• W4366776606 creator A5085704989 @default.
• W4366776606 date "2023-03-20" @default.
• W4366776606 modified "2023-09-28" @default.
• W4366776606 title "[Intravesical instillation of bacillus Calmette-Guerin for non-muscle invasive bladder cancer: outcomes of 421 patients in a single center]." @default.
• W4366776606 cites W1552617282 @default.
• W4366776606 cites W1574412838 @default.
• W4366776606 cites W1863833365 @default.
• W4366776606 cites W1982801335 @default.
• W4366776606 cites W1984798391 @default.
• W4366776606 cites W2002045993 @default.
• W4366776606 cites W2008376912 @default.
• W4366776606 cites W2012206066 @default.
• W4366776606 cites W2037985866 @default.
• W4366776606 cites W2052562958 @default.
• W4366776606 cites W2157588288 @default.
• W4366776606 cites W2601029645 @default.
• W4366776606 cites W2745881922 @default.
• W4366776606 cites W2747551987 @default.
• W4366776606 cites W2787996463 @default.
• W4366776606 cites W2794315407 @default.
• W4366776606 cites W2796353691 @default.
• W4366776606 cites W2969983122 @default.
• W4366776606 cites W3048201207 @default.
• W4366776606 cites W3088784078 @default.
• W4366776606 cites W3092030106 @default.
• W4366776606 cites W3157851117 @default.
• W4366776606 cites W3162779423 @default.
• W4366776606 cites W3215893207 @default.
• W4366776606 cites W4293419182 @default.
• W4366776606 doi "https://doi.org/10.12122/j.issn.1673-4254.2023.03.21" @default.
• W4366776606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37087596" @default.
• W4366776606 hasPublicationYear "2023" @default.
• W4366776606 type Work @default.
• W4366776606 citedByCount "0" @default.
• W4366776606 crossrefType "journal-article" @default.
• W4366776606 hasAuthorship W4366776606A5015576939 @default.
• W4366776606 hasAuthorship W4366776606A5024922053 @default.
• W4366776606 hasAuthorship W4366776606A5029454312 @default.
• W4366776606 hasAuthorship W4366776606A5046767109 @default.
• W4366776606 hasAuthorship W4366776606A5058775061 @default.
• W4366776606 hasAuthorship W4366776606A5068668053 @default.
• W4366776606 hasAuthorship W4366776606A5085704989 @default.
• W4366776606 hasConcept C10515644 @default.
• W4366776606 hasConcept C121608353 @default.
• W4366776606 hasConcept C126322002 @default.
• W4366776606 hasConcept C126894567 @default.
• W4366776606 hasConcept C141071460 @default.
• W4366776606 hasConcept C144301174 @default.
• W4366776606 hasConcept C197934379 @default.
• W4366776606 hasConcept C2777793932 @default.
• W4366776606 hasConcept C2780073493 @default.
• W4366776606 hasConcept C2780352672 @default.
• W4366776606 hasConcept C38180746 @default.
• W4366776606 hasConcept C50382708 @default.
• W4366776606 hasConcept C71924100 @default.
• W4366776606 hasConcept C90924648 @default.
• W4366776606 hasConceptScore W4366776606C10515644 @default.
• W4366776606 hasConceptScore W4366776606C121608353 @default.
• W4366776606 hasConceptScore W4366776606C126322002 @default.
• W4366776606 hasConceptScore W4366776606C126894567 @default.
• W4366776606 hasConceptScore W4366776606C141071460 @default.
• W4366776606 hasConceptScore W4366776606C144301174 @default.
• W4366776606 hasConceptScore W4366776606C197934379 @default.
• W4366776606 hasConceptScore W4366776606C2777793932 @default.
• W4366776606 hasConceptScore W4366776606C2780073493 @default.
• W4366776606 hasConceptScore W4366776606C2780352672 @default.
• W4366776606 hasConceptScore W4366776606C38180746 @default.
• W4366776606 hasConceptScore W4366776606C50382708 @default.
• W4366776606 hasConceptScore W4366776606C71924100 @default.
• W4366776606 hasConceptScore W4366776606C90924648 @default.
• W4366776606 hasIssue "3" @default.
• W4366776606 hasLocation W43667766061 @default.
• W4366776606 hasOpenAccess W4366776606 @default.
• W4366776606 hasPrimaryLocation W43667766061 @default.
• W4366776606 hasRelatedWork W2375628929 @default.
• W4366776606 hasRelatedWork W2386134303 @default.
• W4366776606 hasRelatedWork W2404941759 @default.
• W4366776606 hasRelatedWork W2405817813 @default.
• W4366776606 hasRelatedWork W2465627733 @default.
• W4366776606 hasRelatedWork W2616212697 @default.
• W4366776606 hasRelatedWork W2890272496 @default.
• W4366776606 hasRelatedWork W2996950820 @default.
• W4366776606 hasRelatedWork W3214959689 @default.
• W4366776606 hasRelatedWork W4255845609 @default.
• W4366776606 hasVolume "43" @default.
• W4366776606 isParatext "false" @default.
• W4366776606 isRetracted "false" @default.
• W4366776606 workType "article" @default.